As talks wrap up at the United Nations over ways to address a global tuberculosis epidemic, the U.S. has succeeded in removing language from a policy document that patient advocacy groups claim will make access and affordability more difficult for poorer countries.

Specifically, the U.S. has pressed other nations to change language referring to a World Trade Organization agreement that allows countries to issue compulsory licenses as a way to create lower-cost alternatives to medicines, according to the latest version of the agreement reviewed by STAT.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!